Baton Rouge native develops antiviral drug with potential to fight coronavirus
www.thedrumnewspaper.info
Darnisha Harrison, founder and CEO of Ennaid Therapeutics, is advancing the development of ENU200 that could treat as much as 80 percent of asymptomatic, mild to moderate COVID-19 infections.
Baton Rouge native develops antiviral drug with potential to fight coronavirus
Baton Rouge native develops antiviral drug…
Baton Rouge native develops antiviral drug with potential to fight coronavirus
Darnisha Harrison, founder and CEO of Ennaid Therapeutics, is advancing the development of ENU200 that could treat as much as 80 percent of asymptomatic, mild to moderate COVID-19 infections.